世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の細胞治療（CT）市場の洞察と2028年までの予測


Global Cellular Therapy (CT) Market Insights and Forecast to 2028

細胞治療（CT）とは、生存する細胞を患者に注入・移植・埋め込み、薬効を得る治療法です。例えば、免疫療法では細胞介在性免疫によりがん細胞と闘うT細胞を移植したり、幹細胞を移植して病気の組織を再生したりし... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2022年2月4日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

細胞治療（CT）とは、生存する細胞を患者に注入・移植・埋め込み、薬効を得る治療法です。例えば、免疫療法では細胞介在性免疫によりがん細胞と闘うT細胞を移植したり、幹細胞を移植して病気の組織を再生したりします。
市場分析と洞察。細胞治療（CT）の世界市場
細胞治療（CT）の世界市場規模は、2021年の百万米ドルから2028年には百万米ドルに達すると予測され、2022年から2028年の間、年率％で推移すると予測されています。
この健康危機による経済的変化を十分に考慮し、2021年に細胞治療（CT）世界市場の％を占めていた幹細胞は、COVID-19後の期間に改訂された％のCAGRで成長し、2028年には100万米ドルになると予測されます。一方、病院のセグメントは、この予測期間中、％のCAGRで変化しています。
中国の細胞治療（CT）の市場規模は2021年に百万米ドル、北米と欧州の細胞治療（CT）の市場規模はそれぞれ百万米ドルと百万米ドルとなっています。2021年の北米の割合は%で、中国と欧州はそれぞれ%と%で、中国の割合は2028年に%に達し、分析期間中のCAGRは%になると予測されています。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。欧州の細胞治療（CT）市場では、ドイツが2028年までに100万米ドルに達すると予測されており、予測期間中のCAGRは%です。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の細胞治療（CT）市場で得られる主要な機会を明らかにし、市場での確固たる地位を獲得するための一助となることを目的としています。本レポートの購入者は、世界の細胞治療（CT）市場全体の規模（収益）など、検証済みの信頼できる市場予測にアクセスすることができます。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の細胞治療（CT）市場で永続的な成功を収めるために利用できる効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の細胞治療（CT）市場を詳細に調査するために、ユニークで業界最高の調査・分析手法を用いています。
世界の細胞治療（CT）の範囲と市場規模
細胞治療（CT）市場は、プレイヤー別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界の細胞治療（CT）市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てています。
タイプ別セグメント
幹細胞（Stem Cell
非幹細胞
アプリケーション別セグメント
病院
クリニック
その他
会社別
ギリアド・サイエンシズ
ノバルティス
オシリス
ベリセル・コーポレーション
Vcanbio
富士フイルムセルラーダイナミクス
JCRファーマシューティカルズ
北池バイオ
ゴールデンメディテック
Guanhao Biotech
地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域


ページTOPに戻る


目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cellular Therapy (CT) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cellular Therapy (CT) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cellular Therapy (CT) Market Perspective (2017-2028)
2.2 Cellular Therapy (CT) Growth Trends by Region
2.2.1 Cellular Therapy (CT) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cellular Therapy (CT) Historic Market Size by Region (2017-2022)
2.2.3 Cellular Therapy (CT) Forecasted Market Size by Region (2023-2028)
2.3 Cellular Therapy (CT) Market Dynamics
2.3.1 Cellular Therapy (CT) Industry Trends
2.3.2 Cellular Therapy (CT) Market Drivers
2.3.3 Cellular Therapy (CT) Market Challenges
2.3.4 Cellular Therapy (CT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cellular Therapy (CT) Players by Revenue
3.1.1 Global Top Cellular Therapy (CT) Players by Revenue (2017-2022)
3.1.2 Global Cellular Therapy (CT) Revenue Market Share by Players (2017-2022)
3.2 Global Cellular Therapy (CT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cellular Therapy (CT) Revenue
3.4 Global Cellular Therapy (CT) Market Concentration Ratio
3.4.1 Global Cellular Therapy (CT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cellular Therapy (CT) Revenue in 2021
3.5 Cellular Therapy (CT) Key Players Head office and Area Served
3.6 Key Players Cellular Therapy (CT) Product Solution and Service
3.7 Date of Enter into Cellular Therapy (CT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cellular Therapy (CT) Breakdown Data by Type
4.1 Global Cellular Therapy (CT) Historic Market Size by Type (2017-2022)
4.2 Global Cellular Therapy (CT) Forecasted Market Size by Type (2023-2028)
5 Cellular Therapy (CT) Breakdown Data by Application
5.1 Global Cellular Therapy (CT) Historic Market Size by Application (2017-2022)
5.2 Global Cellular Therapy (CT) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cellular Therapy (CT) Market Size (2017-2028)
6.2 North America Cellular Therapy (CT) Market Size by Type
6.2.1 North America Cellular Therapy (CT) Market Size by Type (2017-2022)
6.2.2 North America Cellular Therapy (CT) Market Size by Type (2023-2028)
6.2.3 North America Cellular Therapy (CT) Market Share by Type (2017-2028)
6.3 North America Cellular Therapy (CT) Market Size by Application
6.3.1 North America Cellular Therapy (CT) Market Size by Application (2017-2022)
6.3.2 North America Cellular Therapy (CT) Market Size by Application (2023-2028)
6.3.3 North America Cellular Therapy (CT) Market Share by Application (2017-2028)
6.4 North America Cellular Therapy (CT) Market Size by Country
6.4.1 North America Cellular Therapy (CT) Market Size by Country (2017-2022)
6.4.2 North America Cellular Therapy (CT) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Cellular Therapy (CT) Market Size (2017-2028)
7.2 Europe Cellular Therapy (CT) Market Size by Type
7.2.1 Europe Cellular Therapy (CT) Market Size by Type (2017-2022)
7.2.2 Europe Cellular Therapy (CT) Market Size by Type (2023-2028)
7.2.3 Europe Cellular Therapy (CT) Market Share by Type (2017-2028)
7.3 Europe Cellular Therapy (CT) Market Size by Application
7.3.1 Europe Cellular Therapy (CT) Market Size by Application (2017-2022)
7.3.2 Europe Cellular Therapy (CT) Market Size by Application (2023-2028)
7.3.3 Europe Cellular Therapy (CT) Market Share by Application (2017-2028)
7.4 Europe Cellular Therapy (CT) Market Size by Country
7.4.1 Europe Cellular Therapy (CT) Market Size by Country (2017-2022)
7.4.2 Europe Cellular Therapy (CT) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cellular Therapy (CT) Market Size (2017-2028)
8.2 Asia-Pacific Cellular Therapy (CT) Market Size by Type
8.2.1 Asia-Pacific Cellular Therapy (CT) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cellular Therapy (CT) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cellular Therapy (CT) Market Share by Type (2017-2028)
8.3 Asia-Pacific Cellular Therapy (CT) Market Size by Application
8.3.1 Asia-Pacific Cellular Therapy (CT) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cellular Therapy (CT) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cellular Therapy (CT) Market Share by Application (2017-2028)
8.4 Asia-Pacific Cellular Therapy (CT) Market Size by Region
8.4.1 Asia-Pacific Cellular Therapy (CT) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cellular Therapy (CT) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cellular Therapy (CT) Market Size (2017-2028)
9.2 Latin America Cellular Therapy (CT) Market Size by Type
9.2.1 Latin America Cellular Therapy (CT) Market Size by Type (2017-2022)
9.2.2 Latin America Cellular Therapy (CT) Market Size by Type (2023-2028)
9.2.3 Latin America Cellular Therapy (CT) Market Share by Type (2017-2028)
9.3 Latin America Cellular Therapy (CT) Market Size by Application
9.3.1 Latin America Cellular Therapy (CT) Market Size by Application (2017-2022)
9.3.2 Latin America Cellular Therapy (CT) Market Size by Application (2023-2028)
9.3.3 Latin America Cellular Therapy (CT) Market Share by Application (2017-2028)
9.4 Latin America Cellular Therapy (CT) Market Size by Country
9.4.1 Latin America Cellular Therapy (CT) Market Size by Country (2017-2022)
9.4.2 Latin America Cellular Therapy (CT) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cellular Therapy (CT) Market Size (2017-2028)
10.2 Middle East & Africa Cellular Therapy (CT) Market Size by Type
10.2.1 Middle East & Africa Cellular Therapy (CT) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cellular Therapy (CT) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cellular Therapy (CT) Market Share by Type (2017-2028)
10.3 Middle East & Africa Cellular Therapy (CT) Market Size by Application
10.3.1 Middle East & Africa Cellular Therapy (CT) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cellular Therapy (CT) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cellular Therapy (CT) Market Share by Application (2017-2028)
10.4 Middle East & Africa Cellular Therapy (CT) Market Size by Country
10.4.1 Middle East & Africa Cellular Therapy (CT) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cellular Therapy (CT) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Cellular Therapy (CT) Introduction
11.1.4 Gilead Sciences Revenue in Cellular Therapy (CT) Business (2017-2022)
11.1.5 Gilead Sciences Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Cellular Therapy (CT) Introduction
11.2.4 Novartis Revenue in Cellular Therapy (CT) Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 Osiris
11.3.1 Osiris Company Details
11.3.2 Osiris Business Overview
11.3.3 Osiris Cellular Therapy (CT) Introduction
11.3.4 Osiris Revenue in Cellular Therapy (CT) Business (2017-2022)
11.3.5 Osiris Recent Developments
11.4 Vericel Corporation
11.4.1 Vericel Corporation Company Details
11.4.2 Vericel Corporation Business Overview
11.4.3 Vericel Corporation Cellular Therapy (CT) Introduction
11.4.4 Vericel Corporation Revenue in Cellular Therapy (CT) Business (2017-2022)
11.4.5 Vericel Corporation Recent Developments
11.5 Vcanbio
11.5.1 Vcanbio Company Details
11.5.2 Vcanbio Business Overview
11.5.3 Vcanbio Cellular Therapy (CT) Introduction
11.5.4 Vcanbio Revenue in Cellular Therapy (CT) Business (2017-2022)
11.5.5 Vcanbio Recent Developments
11.6 Fujifilm Cellular Dynamics
11.6.1 Fujifilm Cellular Dynamics Company Details
11.6.2 Fujifilm Cellular Dynamics Business Overview
11.6.3 Fujifilm Cellular Dynamics Cellular Therapy (CT) Introduction
11.6.4 Fujifilm Cellular Dynamics Revenue in Cellular Therapy (CT) Business (2017-2022)
11.6.5 Fujifilm Cellular Dynamics Recent Developments
11.7 JCR Pharmaceuticals
11.7.1 JCR Pharmaceuticals Company Details
11.7.2 JCR Pharmaceuticals Business Overview
11.7.3 JCR Pharmaceuticals Cellular Therapy (CT) Introduction
11.7.4 JCR Pharmaceuticals Revenue in Cellular Therapy (CT) Business (2017-2022)
11.7.5 JCR Pharmaceuticals Recent Developments
11.8 Beike Biotechnology
11.8.1 Beike Biotechnology Company Details
11.8.2 Beike Biotechnology Business Overview
11.8.3 Beike Biotechnology Cellular Therapy (CT) Introduction
11.8.4 Beike Biotechnology Revenue in Cellular Therapy (CT) Business (2017-2022)
11.8.5 Beike Biotechnology Recent Developments
11.9 Golden Meditech
11.9.1 Golden Meditech Company Details
11.9.2 Golden Meditech Business Overview
11.9.3 Golden Meditech Cellular Therapy (CT) Introduction
11.9.4 Golden Meditech Revenue in Cellular Therapy (CT) Business (2017-2022)
11.9.5 Golden Meditech Recent Developments
11.10 Guanhao Biotech
11.10.1 Guanhao Biotech Company Details
11.10.2 Guanhao Biotech Business Overview
11.10.3 Guanhao Biotech Cellular Therapy (CT) Introduction
11.10.4 Guanhao Biotech Revenue in Cellular Therapy (CT) Business (2017-2022)
11.10.5 Guanhao Biotech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

　

ページTOPに戻る


　

Summary

Cellular therapy (CT) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
Market Analysis and Insights: Global Cellular Therapy (CT) Market
The global Cellular Therapy (CT) market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Stem Cell accounting for % of the Cellular Therapy (CT) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Cellular Therapy (CT) market size is valued at US$ million in 2021, while the North America and Europe Cellular Therapy (CT) are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cellular Therapy (CT) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cellular Therapy (CT) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cellular Therapy (CT) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cellular Therapy (CT) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cellular Therapy (CT) market.
Global Cellular Therapy (CT) Scope and Market Size
Cellular Therapy (CT) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cellular Therapy (CT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Stem Cell
Non-Stem Cell
Segment by Application
Hospitals
Clinics
Others
By Company
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA



ページTOPに戻る


Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cellular Therapy (CT) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cellular Therapy (CT) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cellular Therapy (CT) Market Perspective (2017-2028)
2.2 Cellular Therapy (CT) Growth Trends by Region
2.2.1 Cellular Therapy (CT) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cellular Therapy (CT) Historic Market Size by Region (2017-2022)
2.2.3 Cellular Therapy (CT) Forecasted Market Size by Region (2023-2028)
2.3 Cellular Therapy (CT) Market Dynamics
2.3.1 Cellular Therapy (CT) Industry Trends
2.3.2 Cellular Therapy (CT) Market Drivers
2.3.3 Cellular Therapy (CT) Market Challenges
2.3.4 Cellular Therapy (CT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cellular Therapy (CT) Players by Revenue
3.1.1 Global Top Cellular Therapy (CT) Players by Revenue (2017-2022)
3.1.2 Global Cellular Therapy (CT) Revenue Market Share by Players (2017-2022)
3.2 Global Cellular Therapy (CT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cellular Therapy (CT) Revenue
3.4 Global Cellular Therapy (CT) Market Concentration Ratio
3.4.1 Global Cellular Therapy (CT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cellular Therapy (CT) Revenue in 2021
3.5 Cellular Therapy (CT) Key Players Head office and Area Served
3.6 Key Players Cellular Therapy (CT) Product Solution and Service
3.7 Date of Enter into Cellular Therapy (CT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cellular Therapy (CT) Breakdown Data by Type
4.1 Global Cellular Therapy (CT) Historic Market Size by Type (2017-2022)
4.2 Global Cellular Therapy (CT) Forecasted Market Size by Type (2023-2028)
5 Cellular Therapy (CT) Breakdown Data by Application
5.1 Global Cellular Therapy (CT) Historic Market Size by Application (2017-2022)
5.2 Global Cellular Therapy (CT) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cellular Therapy (CT) Market Size (2017-2028)
6.2 North America Cellular Therapy (CT) Market Size by Type
6.2.1 North America Cellular Therapy (CT) Market Size by Type (2017-2022)
6.2.2 North America Cellular Therapy (CT) Market Size by Type (2023-2028)
6.2.3 North America Cellular Therapy (CT) Market Share by Type (2017-2028)
6.3 North America Cellular Therapy (CT) Market Size by Application
6.3.1 North America Cellular Therapy (CT) Market Size by Application (2017-2022)
6.3.2 North America Cellular Therapy (CT) Market Size by Application (2023-2028)
6.3.3 North America Cellular Therapy (CT) Market Share by Application (2017-2028)
6.4 North America Cellular Therapy (CT) Market Size by Country
6.4.1 North America Cellular Therapy (CT) Market Size by Country (2017-2022)
6.4.2 North America Cellular Therapy (CT) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Cellular Therapy (CT) Market Size (2017-2028)
7.2 Europe Cellular Therapy (CT) Market Size by Type
7.2.1 Europe Cellular Therapy (CT) Market Size by Type (2017-2022)
7.2.2 Europe Cellular Therapy (CT) Market Size by Type (2023-2028)
7.2.3 Europe Cellular Therapy (CT) Market Share by Type (2017-2028)
7.3 Europe Cellular Therapy (CT) Market Size by Application
7.3.1 Europe Cellular Therapy (CT) Market Size by Application (2017-2022)
7.3.2 Europe Cellular Therapy (CT) Market Size by Application (2023-2028)
7.3.3 Europe Cellular Therapy (CT) Market Share by Application (2017-2028)
7.4 Europe Cellular Therapy (CT) Market Size by Country
7.4.1 Europe Cellular Therapy (CT) Market Size by Country (2017-2022)
7.4.2 Europe Cellular Therapy (CT) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cellular Therapy (CT) Market Size (2017-2028)
8.2 Asia-Pacific Cellular Therapy (CT) Market Size by Type
8.2.1 Asia-Pacific Cellular Therapy (CT) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cellular Therapy (CT) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cellular Therapy (CT) Market Share by Type (2017-2028)
8.3 Asia-Pacific Cellular Therapy (CT) Market Size by Application
8.3.1 Asia-Pacific Cellular Therapy (CT) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cellular Therapy (CT) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cellular Therapy (CT) Market Share by Application (2017-2028)
8.4 Asia-Pacific Cellular Therapy (CT) Market Size by Region
8.4.1 Asia-Pacific Cellular Therapy (CT) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cellular Therapy (CT) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cellular Therapy (CT) Market Size (2017-2028)
9.2 Latin America Cellular Therapy (CT) Market Size by Type
9.2.1 Latin America Cellular Therapy (CT) Market Size by Type (2017-2022)
9.2.2 Latin America Cellular Therapy (CT) Market Size by Type (2023-2028)
9.2.3 Latin America Cellular Therapy (CT) Market Share by Type (2017-2028)
9.3 Latin America Cellular Therapy (CT) Market Size by Application
9.3.1 Latin America Cellular Therapy (CT) Market Size by Application (2017-2022)
9.3.2 Latin America Cellular Therapy (CT) Market Size by Application (2023-2028)
9.3.3 Latin America Cellular Therapy (CT) Market Share by Application (2017-2028)
9.4 Latin America Cellular Therapy (CT) Market Size by Country
9.4.1 Latin America Cellular Therapy (CT) Market Size by Country (2017-2022)
9.4.2 Latin America Cellular Therapy (CT) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cellular Therapy (CT) Market Size (2017-2028)
10.2 Middle East & Africa Cellular Therapy (CT) Market Size by Type
10.2.1 Middle East & Africa Cellular Therapy (CT) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cellular Therapy (CT) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cellular Therapy (CT) Market Share by Type (2017-2028)
10.3 Middle East & Africa Cellular Therapy (CT) Market Size by Application
10.3.1 Middle East & Africa Cellular Therapy (CT) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cellular Therapy (CT) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cellular Therapy (CT) Market Share by Application (2017-2028)
10.4 Middle East & Africa Cellular Therapy (CT) Market Size by Country
10.4.1 Middle East & Africa Cellular Therapy (CT) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cellular Therapy (CT) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Cellular Therapy (CT) Introduction
11.1.4 Gilead Sciences Revenue in Cellular Therapy (CT) Business (2017-2022)
11.1.5 Gilead Sciences Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Cellular Therapy (CT) Introduction
11.2.4 Novartis Revenue in Cellular Therapy (CT) Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 Osiris
11.3.1 Osiris Company Details
11.3.2 Osiris Business Overview
11.3.3 Osiris Cellular Therapy (CT) Introduction
11.3.4 Osiris Revenue in Cellular Therapy (CT) Business (2017-2022)
11.3.5 Osiris Recent Developments
11.4 Vericel Corporation
11.4.1 Vericel Corporation Company Details
11.4.2 Vericel Corporation Business Overview
11.4.3 Vericel Corporation Cellular Therapy (CT) Introduction
11.4.4 Vericel Corporation Revenue in Cellular Therapy (CT) Business (2017-2022)
11.4.5 Vericel Corporation Recent Developments
11.5 Vcanbio
11.5.1 Vcanbio Company Details
11.5.2 Vcanbio Business Overview
11.5.3 Vcanbio Cellular Therapy (CT) Introduction
11.5.4 Vcanbio Revenue in Cellular Therapy (CT) Business (2017-2022)
11.5.5 Vcanbio Recent Developments
11.6 Fujifilm Cellular Dynamics
11.6.1 Fujifilm Cellular Dynamics Company Details
11.6.2 Fujifilm Cellular Dynamics Business Overview
11.6.3 Fujifilm Cellular Dynamics Cellular Therapy (CT) Introduction
11.6.4 Fujifilm Cellular Dynamics Revenue in Cellular Therapy (CT) Business (2017-2022)
11.6.5 Fujifilm Cellular Dynamics Recent Developments
11.7 JCR Pharmaceuticals
11.7.1 JCR Pharmaceuticals Company Details
11.7.2 JCR Pharmaceuticals Business Overview
11.7.3 JCR Pharmaceuticals Cellular Therapy (CT) Introduction
11.7.4 JCR Pharmaceuticals Revenue in Cellular Therapy (CT) Business (2017-2022)
11.7.5 JCR Pharmaceuticals Recent Developments
11.8 Beike Biotechnology
11.8.1 Beike Biotechnology Company Details
11.8.2 Beike Biotechnology Business Overview
11.8.3 Beike Biotechnology Cellular Therapy (CT) Introduction
11.8.4 Beike Biotechnology Revenue in Cellular Therapy (CT) Business (2017-2022)
11.8.5 Beike Biotechnology Recent Developments
11.9 Golden Meditech
11.9.1 Golden Meditech Company Details
11.9.2 Golden Meditech Business Overview
11.9.3 Golden Meditech Cellular Therapy (CT) Introduction
11.9.4 Golden Meditech Revenue in Cellular Therapy (CT) Business (2017-2022)
11.9.5 Golden Meditech Recent Developments
11.10 Guanhao Biotech
11.10.1 Guanhao Biotech Company Details
11.10.2 Guanhao Biotech Business Overview
11.10.3 Guanhao Biotech Cellular Therapy (CT) Introduction
11.10.4 Guanhao Biotech Revenue in Cellular Therapy (CT) Business (2017-2022)
11.10.5 Guanhao Biotech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（移動通信）の最新刊レポート

QYResearch社の移動通信分野での最新刊レポート

本レポートと同じKEY WORD（cellular）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/20　10:26

155.91 円

165.77 円

200.60 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.